STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

FMR/Abigail Johnson disclose 17.08M BRKR shares (11.0% ownership)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

FMR LLC and Abigail P. Johnson report beneficial ownership of 17,082,319.90 shares of Bruker Corporation common stock, representing 11.0% of the outstanding class. The filing, a Schedule 13G/A, indicates these shares are held in the ordinary course of business and not for the purpose of changing control. The report shows FMR LLC with 13,832,390.78 shares of sole voting power and 17,082,319.90 shares of sole dispositive power; Abigail P. Johnson is reported with sole dispositive power over 17,082,319.90 shares and no voting power. The filing references an event date of 09/30/2025 and is signed on 10/06/2025. An Exhibit 99 agreement is attached per the document.

Positive

  • Clear reporting of material stake: the filing discloses an 11.0% ownership position (17,082,319.90 shares)
  • Passive intent stated: certification that holdings are in the ordinary course of business and not to change control
  • Documented voting/dispositive powers: FMR LLC reports specific sole voting and dispositive power figures

Negative

  • No disclosure of underlying accounts or funds that account for the shares beyond general statement that others may have dividend/proceeds rights
  • Potential governance concentration: a single reporting group holds a material 11.0% stake which could affect shareholder votes if strategy changes
  • Limited detail on Exhibit 99: the referenced agreement is not summarized in the filing text

Insights

Large passive stake: 11.0% ownership signals material institutional exposure.

Holding 17,082,319.90 shares and representing 11.0% of the class makes this a material position that could influence liquidity and shareholder voting outcomes simply by its size. The filing states the position is held in the ordinary course of business and not to change control, which aligns with a passive investment posture.

This position includes clear voting and dispositive power allocations: FMR LLC reports 13,832,390.78 shares of sole voting power and 17,082,319.90 shares of sole dispositive power. Investors may watch any subsequent amendments, changes in voting/dispositive power, or related Exhibit 99 details over the next 3–12 months for signs of strategy changes.

Significant individual and parent reporting with explicit certifications and POAs.

The filing lists both FMR LLC and Abigail P. Johnson as reporting persons, with powers documented via powers of attorney incorporated by reference to earlier exhibits. The certification asserts the securities were not acquired to influence control and were acquired in the ordinary course of business.

Key items to monitor include the referenced Exhibit 99 agreement and any future Schedule 13D/A or 13G amendments that would change the stated intent or ownership percentages; relevant updates could appear within the next reporting cycle.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:10/06/2025
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:10/06/2025

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

What stake does FMR LLC report in BRKR?

FMR LLC reports beneficial ownership of 17,082,319.90 shares, equal to 11.0% of the common stock class.

Does Abigail P. Johnson hold voting power in BRKR?

The filing shows Abigail P. Johnson has 0 sole voting power and 17,082,319.90 sole dispositive power over the shares.

Was the BRKR position acquired to change control?

The certifying statement declares the securities were acquired and are held in the ordinary course of business and not to change or influence control.

When is the event date reported for this Schedule 13G/A?

The filing lists the date of the event requiring this statement as 09/30/2025 and is signed on 10/06/2025.

Where can I find details of the subsidiary/group agreement?

The filing references an Exhibit 99 for the 13d-1(k)(1) agreement; the filing text does not summarize its contents.
Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

7.05B
103.37M
31.98%
84.57%
5.51%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA